Susan G. Komen For The Cure(R) Encourages Continued Coverage For Avastin For Breast C
 

Susan G. Komen for the Cure® encouraged continued coverage for breast cancer patients benefitting from the cancer drug Avastin and the continued development of breast cancer treatments, following a U.S. Food and Drug Administration (FDA) decision to begin the process of removing approval of Avastin as a treatment for metastatic breast cancer...

More...